Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Digestive diseases Stories

2012-03-21 14:05:42

Researchers from the Hotchkiss Brain Institute (HBI) and the Snyder Institute for Chronic Diseases at the University of Calgary's Faculty of Medicine have discovered a pathway that may contribute to the symptoms related to Crohn's disease and ulcerative colitis, collectively known as Inflammatory Bowel Disease (IBD). This research is a major milestone in developing future drug therapies for those living with these debilitating disorders. The digestive process is complex. To coordinate the...

2012-03-19 16:50:32

Despite advances in neonatal care, necrotizing enterocolitis (NEC) — the most common gastrointestinal emergency in premature infants — continues to be a deadly disease. “We haven´t made a lot of progress in identifying babies early who may be at risk for NEC, preventing it or treating it,” said Jörn-Hendrik Weitkamp, M.D., a neonatologist and assistant professor of Pediatrics at Monroe Carell Jr. Children's Hospital at Vanderbilt. Now, Weitkamp...

2012-03-19 16:15:29

The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) research team at Virginia Tech has discovered important new information on the efficacy of conjugated linoleic acid (CLA) in treating Crohn´s disease, a form of inflammatory bowel disease (IBD).  CLA is a naturally occurring acid found in meat and dairy products known for its anti-cancer and immune modulatory properties. In collaboration with the Division of Gastroenterology and Hepathology at University of...

2012-03-19 06:24:29

LEXINGTON, Mass., March 19, 2012 /PRNewswire/ -- Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, is proud to announce that it has received a second round of funding from the National Institutes of Health for its work in inflammatory bowel disease. Avaxia Biologics has been awarded a Phase II Small Business Innovation Research (SBIR) grant...

2012-03-14 07:00:00

According to court documents, on February 27th, 2012 the New Jersey Supreme Court ruled that Kamie S. Kendall, the plaintiff in a $10.5 million lawsuit over Accutane, did not miss the state's two-year statute of limitations when she filed the suit in 2005 (A-73-2010 — 066802). Accutane (isotretinoin), a popular acne medication introduced in 1982, is manufactured by Hoffman-LaRoche, Inc. Kendall, who accuses Accutane for her ulcerative colitis, started taking Accutane for her acne in...

2012-03-12 21:17:38

Many children with Crohn´s disease and ulcerative colitis who received treatment through ImproveCareNow, a national quality improvement and research network, ceased to have symptoms and no longer needed to take steroids for disease management. These are the findings from a study appearing in Pediatrics that examined the ImproveCareNow network´s quality improvement efforts and their impact on outcomes. In this study, the proportion of children with Crohn´s disease who were in...

2012-03-09 13:30:00

In the largest study of its kind, researchers from Mount Sinai School of Medicine have discovered five new genetic mutations associated with Crohn´s disease in Jews of Eastern European descent, also known as Ashkenazi Jews. The findings are the first step in an attempt to explain why the prevalence of Crohn´s disease is nearly four times higher in Ashkenazi Jews than in other populations. New York, NY (PRWEB) March 09, 2012 In the largest study of its kind, researchers from Mount...

2012-03-09 10:53:06

In the largest study of its kind, researchers from Mount Sinai School of Medicine have discovered five new genetic mutations associated with Crohn's disease in Jews of Eastern European descent, also known as Ashkenazi Jews. The findings, which appear in the March 8 online edition of PLoS Genetics, are the first step in an attempt to explain why the prevalence of Crohn's disease is nearly four times higher in Ashkenazi Jews than in other populations. Crohn's disease was first characterized...

2012-03-09 10:41:33

Researchers from Mount Sinai School of Medicine have discovered 5 new genetic mutations associated with Crohn's disease in Jews of Eastern European descent, often referred to as Ashkenazi Jews Researchers from Mount Sinai School of Medicine have discovered five new genetic mutations associated with Crohn's disease in Jews of Eastern European descent, often referred to as Ashkenazi Jews. The findings, published in PLoS Genetics, are the first step in an attempt to explain why the prevalence...

2012-03-09 07:47:00

MANHASSET, N.Y., March 9, 2012 /PRNewswire-USNewswire/ -- A collaborative group of investigators has joined together to identify five genetic variations associated with Crohn's disease (CD) and Jewish individuals of Eastern and Central European decent, who are also known as Ashkenazi Jews. These findings were published in the March issue of PLoS Genetics. CD causes inflammation of the lining of the digestive tract and can be both painful and debilitating, and sometimes may lead to...